30.1.2024 10:34:32 CET | Aqua Bio Technology ASA | Additional regulated information required to be disclosed under the laws of a member state

Reference is made to the announcement by Aqua Bio Technology ASA on 30 January 2024 concerning, among other things, a private placement with total gross proceeds of approximately NOK 12.46 million and a contemplated subsequent offering (the "Subsequent Offering").

 

Date on which the terms of the Subsequent Offering was announced:

29 January 2024

Last day including right:

30 January 2024

First day excluding right:

31 January 2024

Record date:

1 February 2024

Resolution date:

30 January 2024

Maximum number of new shares:

1,000,000

Subscription price:

NOK 5

Shall the rights be listed

No

 

The formal resolution related to the Subsequent Offering will be made by the board of directors at a later time, and further information will be given in due course.

 

This information is published in accordance with the requirements of the Continuing Obligations.

 

 

Disclosure regulation

This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.

Contacts

  • Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

About Aqua Bio Technology ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

Attachments

  • Download announcement as PDF.pdf

© NTB Norway, source NTB English Regulatory Releases